Cleaving Beclin 1 to suppress autophagy in chemotherapy-induced apoptosis

37Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Autophagy is often found in apoptosis-defective cancer cells and contributes to chemotherapy resistance. However, it is far from clear how the coordination of apoptosis and autophagy determines sensitivity of cancer cells to chemotherapy. Our recent study showed that Beclin 1, a key regulator of autophagy, is cleaved by caspase 8 at the execution stage of chemotherapy-induced and mitochondria-mediated apoptosis. Perturbation of Beclin 1 cleavage, by knock-in of a mutation, phenocopies the autophagy observed in apoptosis-defective cancer cells, and renders chemotherapy resistance in vitro and in vivo. These results demonstrate an important role of caspases in suppressing autophagy by cleaving autophagic machinery. © 2011 Landes Bioscience.

Cite

CITATION STYLE

APA

Li, H., Wang, P., Yu, J., & Zhang, L. (2011). Cleaving Beclin 1 to suppress autophagy in chemotherapy-induced apoptosis. Autophagy, 7(10), 1239–1241. https://doi.org/10.4161/auto.7.10.16490

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free